Skip to main content
KENGREAL 50 mg/1 injection, powder, lyophilized, for solution by Chiesi USA, Inc.
KENGREAL, 50 mg/1, injection, powder, lyophilized, for solution Drug class: P2Y12 Platelet Inhibitor. Available on prescription only. Listed by Chiesi USA, Inc..
Prescription only

KENGREAL

cangrelor

Listed by Chiesi USA, Inc.

Strength
50 mg/1
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
P2Y12 Platelet Inhibitor

What it contains

  • Cangrelor 50 mg/1

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class P2Y12 Platelet Inhibitor
Approval route NDA — original brand approval
NDC code 10122-620
FDA application NDA204958
RxNorm concept 1656056
Package sizes listed 1
Marketed since July 2015

Other products containing Cangrelor

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Cangrelor

Strength
50 mg/1
Form
Injection, Powder, Lyophilized, For Solution
Class
P2Y12 Platelet Inhibitor
Rx only Generic

Gland Pharma Limited

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.